Table 2.

HRs for the incident detection of oncogenic HPV infection as estimated using a WLW model

CD4 T-cell count (cells per mm3)HIV RNA (copies per mL)HR (95% CI)
>500<4,0001.61 (1.23-2.10)
4,001-20,0002.03 (1.39-2.97)
20,001-100,0003.06 (1.96-4.76)
>100,0003.40 (1.82-6.32)
200-500<4,0002.58 (2.02-3.30)
4,001-20,0003.15 (2.37-4.18)
20,001-100,0004.02 (3.02-5.35)
>100,0004.77 (3.47-6.56)
<200<4,0004.55 (3.33-6.21)
4,001-20,0005.10 (3.70-7.03)
20,001-100,0004.55 (3.38-6.12)
>100,0004.87 (3.75-6.34)

NOTE: HIV-negative women were the reference group. The WLW model [model (1.10)] adjusted for the same variables reported in Table 1.